Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 2g2h | P16 | Tyrosine-protein kinase ABL1 | 2.7.10.2 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 2g2h | P16 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 1.000 | |
| 4xey | 1N1 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.566 | |
| 1m52 | P17 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.562 | |
| 4af3 | VX6 | Aurora kinase B | 2.7.11.1 | 0.545 | |
| 1byg | STU | Tyrosine-protein kinase CSK | / | 0.544 | |
| 3oct | 1N1 | Tyrosine-protein kinase BTK | 2.7.10.2 | 0.538 | |
| 4twp | AXI | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.534 | |
| 2gqg | 1N1 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.530 | |
| 3ue4 | DB8 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.530 | |
| 2f4j | VX6 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.519 | |
| 4wa9 | AXI | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.517 | |
| 5bvw | 1N1 | Epithelial discoidin domain-containing receptor 1 | 2.7.10.1 | 0.516 | |
| 2xyn | VX6 | Abelson tyrosine-protein kinase 2 | 2.7.10.2 | 0.508 | |
| 4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.505 | |
| 3ad6 | KSC | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.502 | |
| 2vwx | 7X4 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.500 | |
| 2of4 | 979 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.499 | |
| 2of2 | 547 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.498 | |
| 2zm1 | KSF | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.495 | |
| 3ac2 | KSE | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.495 | |
| 2rl5 | 2RL | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.494 | |
| 2g2f | AGS | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.493 | |
| 2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.492 | |
| 3a4o | STU | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.491 | |
| 3ac3 | KSH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.491 | |
| 2hk5 | 1BM | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.490 | |
| 1jpa | ANP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.489 | |
| 3oom | 507 | Activin receptor type-1 | 2.7.11.30 | 0.488 | |
| 4bb3 | KKA | Isopenicillin N synthase | 1.21.3.1 | 0.487 | |
| 3ds6 | A17 | Mitogen-activated protein kinase 14 | / | 0.486 | |
| 2vx0 | 7X7 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.485 | |
| 4mxx | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.485 | |
| 2p15 | EZT | Estrogen receptor | / | 0.484 | |
| 4id7 | 1G0 | Activated CDC42 kinase 1 | / | 0.484 | |
| 4mxo | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.484 | |
| 2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.483 | |
| 3c0g | 3AM | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.483 | |
| 5ajq | DB8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.482 | |
| 1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.481 | |
| 2xvd | AS6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.481 | |
| 3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.481 | |
| 3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.481 | |
| 4gk4 | L90 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.481 | |
| 2y6o | 1N1 | Ephrin type-A receptor 4 | 2.7.10.1 | 0.480 | |
| 1qpd | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.479 | |
| 2bdj | HET | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.479 | |
| 3h1j | SMA | Cytochrome b | / | 0.479 | |
| 4c58 | 824 | Cyclin-G-associated kinase | 2.7.11.1 | 0.478 | |
| 4ia2 | BIV | Vitamin D3 receptor A | / | 0.477 | |
| 4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.477 | |
| 4gmy | 0X5 | Tyrosine-protein kinase JAK2 | / | 0.476 | |
| 4jbt | ASD | Cytochrome P450 monooxygenase | / | 0.476 | |
| 4jbq | VX6 | Aurora kinase A | 2.7.11.1 | 0.475 | |
| 3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.474 | |
| 2y30 | SM8 | Putative repressor SimReg2 | / | 0.473 | |
| 3itz | P66 | Mitogen-activated protein kinase 14 | / | 0.473 | |
| 3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.473 | |
| 3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.473 | |
| 4bgg | 844 | Activin receptor type-1 | 2.7.11.30 | 0.473 | |
| 2ycr | HCW | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.472 | |
| 2zyb | KSL | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.472 | |
| 3ac1 | KZI | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.472 | |
| 3cyl | VIT | Basic phospholipase A2 homolog piratoxin-2 | / | 0.472 | |
| 4wuo | NAD | 3-isopropylmalate dehydrogenase | 1.1.1.85 | 0.472 | |
| 5k2b | ZMA | Adenosine receptor A2a | / | 0.472 | |
| 2w9s | TOP | Dihydrofolate reductase type 1 from Tn4003 | 1.5.1.3 | 0.471 | |
| 3b8q | 900 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.471 | |
| 4bii | PYW | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.471 | |
| 4jlj | 1NM | Deoxycytidine kinase | 2.7.1.74 | 0.471 | |
| 5hwq | CAA | Hydroxymethylglutaryl-CoA synthase | / | 0.471 | |
| 2vwy | 7X5 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.470 | |
| 2x9f | X9F | Ephrin type-B receptor 4 | 2.7.10.1 | 0.470 | |
| 3vs4 | VSF | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.470 | |
| 2vx1 | 7X8 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.469 | |
| 3zsh | 469 | Mitogen-activated protein kinase 14 | / | 0.469 | |
| 4elf | 35I | Dihydrofolate reductase | / | 0.469 | |
| 4gk3 | L87 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.469 | |
| 2fb8 | 215 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.468 | |
| 2hzi | JIN | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.468 | |
| 2vwu | 7X1 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.468 | |
| 2xyu | Q9G | Ephrin type-A receptor 4 | 2.7.10.1 | 0.468 | |
| 3gyt | DL4 | Nuclear hormone receptor of the steroid/thyroid hormone receptors superfamily | / | 0.468 | |
| 4jvf | 17X | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.468 | |
| 2py3 | ACP | Fibroblast growth factor receptor 2 | / | 0.467 | |
| 2vwz | 7X6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.467 | |
| 3w1f | 1O5 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.467 | |
| 4feq | 0T8 | Tyrosine-protein kinase receptor TYRO3 | 2.7.10.1 | 0.467 | |
| 5e8w | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.467 | |
| 1hb3 | SCV | Isopenicillin N synthase | 1.21.3.1 | 0.466 | |
| 2oh4 | GIG | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.466 | |
| 3qlf | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.466 | |
| 4fuy | EK2 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.466 | |
| 4g2f | C07 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.466 | |
| 4jlk | 1NO | Deoxycytidine kinase | 2.7.1.74 | 0.466 | |
| 4rup | H97 | Vitamin D3 receptor A | / | 0.466 | |
| 2j0k | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.465 | |
| 2ofv | 242 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.465 | |
| 2vcm | M11 | Isopenicillin N synthase | 1.21.3.1 | 0.465 | |
| 3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.465 | |
| 4bb4 | 32W | Ephrin type-B receptor 4 | 2.7.10.1 | 0.465 | |
| 4mcv | 29K | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.465 | |
| 4o70 | 1QK | Bromodomain-containing protein 4 | / | 0.465 | |
| 2b1p | AIZ | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.464 | |
| 2w0j | ZAT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.464 | |
| 2zm4 | KSM | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.464 | |
| 3e92 | G6A | Mitogen-activated protein kinase 14 | / | 0.464 | |
| 3mtf | A3F | Activin receptor type-1 | 2.7.11.30 | 0.464 | |
| 4xli | 1N1 | Abelson tyrosine-protein kinase 2 | 2.7.10.2 | 0.464 | |
| 5e8x | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.464 | |
| 1blz | ACV | Isopenicillin N synthase | 1.21.3.1 | 0.463 | |
| 1oc1 | ASV | Isopenicillin N synthase | 1.21.3.1 | 0.463 | |
| 2jed | LG8 | Protein kinase C theta type | 2.7.11.13 | 0.463 | |
| 2vww | 7X2 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.463 | |
| 2zva | 1N1 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.463 | |
| 3ada | NAD | Subunit alpha of sarocosine oxidase | / | 0.463 | |
| 3l0l | HC3 | Nuclear receptor ROR-gamma | / | 0.463 | |
| 3qri | 919 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.463 | |
| 3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.463 | |
| 4j97 | ACP | Fibroblast growth factor receptor 2 | / | 0.463 | |
| 4jib | 1L6 | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.463 | |
| 1iyz | NDP | Probable quinone oxidoreductase | / | 0.462 | |
| 1qiq | ACC | Isopenicillin N synthase | 1.21.3.1 | 0.462 | |
| 2o65 | MYF | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.462 | |
| 3gxl | QIG | TGF-beta receptor type-1 | 2.7.11.30 | 0.462 | |
| 3qlg | 1N1 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.462 | |
| 4grb | 0XG | Casein kinase II subunit alpha | 2.7.11.1 | 0.462 | |
| 4iui | 1GQ | Estrogen receptor | / | 0.462 | |
| 4u97 | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.462 | |
| 3pwh | ZMA | Adenosine receptor A2a | / | 0.462 | |
| 2itq | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.461 | |
| 2zv9 | PP2 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.461 | |
| 3be2 | RAJ | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.461 | |
| 3ssn | MVI | Mycinamicin VI 2''-O-methyltransferase | / | 0.461 | |
| 3wd9 | QPC | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.461 | |
| 4ele | 31I | Dihydrofolate reductase | / | 0.461 | |
| 4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.461 | |
| 4riy | ADP | Epidermal growth factor receptor | 2.7.10.1 | 0.461 | |
| 4wo5 | 324 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.461 | |
| 1hb1 | OCV | Isopenicillin N synthase | 1.21.3.1 | 0.460 | |
| 1nq7 | ARL | Nuclear receptor ROR-beta | / | 0.460 | |
| 2qoq | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.460 | |
| 3acj | KSS | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.460 | |
| 3q5i | ANP | Protein kinase, putative | / | 0.460 | |
| 4j6b | PLO | Cytochrome P450 monooxygenase | / | 0.460 | |
| 4mf0 | 29Z | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.460 | |
| 2itv | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.459 | |
| 2y6f | M9F | Isopenicillin N synthase | 1.21.3.1 | 0.459 | |
| 2znn | S44 | Peroxisome proliferator-activated receptor alpha | / | 0.459 | |
| 3c5u | P41 | Mitogen-activated protein kinase 14 | / | 0.459 | |
| 3gc8 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.459 | |
| 3l8s | BFF | Mitogen-activated protein kinase 14 | / | 0.459 | |
| 4im2 | BX7 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.459 | |
| 4ite | TEY | Vitamin D3 receptor | / | 0.459 | |
| 4j6c | STR | Cytochrome P450 monooxygenase | / | 0.459 | |
| 4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.459 | |
| 4tuv | CPZ | Cytochrome P450 119 | 1.14 | 0.459 | |
| 1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.458 | |
| 1w06 | W05 | Isopenicillin N synthase | 1.21.3.1 | 0.458 | |
| 2g78 | REA | Cellular retinoic acid-binding protein 2 | / | 0.458 | |
| 2vbp | VB1 | Isopenicillin N synthase | 1.21.3.1 | 0.458 | |
| 3a1l | 2CC | Cytochrome P450 | / | 0.458 | |
| 3cjf | SAV | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.458 | |
| 3zk5 | Z18 | Cytochrome P450 monooxygenase PikC | / | 0.458 | |
| 1ly3 | COG | Dihydrofolate reductase | 1.5.1.3 | 0.457 | |
| 1pp9 | SMA | Cytochrome b | / | 0.457 | |
| 1ppj | ANY | Cytochrome b | / | 0.457 | |
| 2e98 | B29 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.457 | |
| 2izr | BRK | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.457 | |
| 3ac5 | KZM | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.457 | |
| 3dtc | VIN | Mitogen-activated protein kinase kinase kinase 9 | 2.7.11.25 | 0.457 | |
| 3el8 | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.457 | |
| 3p3z | P3Z | Putative cytochrome P450 | / | 0.457 | |
| 4hgl | 0YO | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.457 | |
| 1y60 | H4M | 5,6,7,8-tetrahydromethanopterin hydro-lyase | 4.2.1.147 | 0.456 | |
| 2ban | 357 | Gag-Pol polyprotein | 2.7.7.49 | 0.456 | |
| 2c47 | 5ID | Casein kinase I isoform gamma-2 | / | 0.456 | |
| 2itn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.456 | |
| 2qoc | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.456 | |
| 4hvs | 647 | Mast/stem cell growth factor receptor Kit | 2.7.10.1 | 0.456 | |
| 4mxy | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.456 | |
| 4mxz | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.456 | |
| 4nky | 3QZ | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.456 | |
| 1okz | UCN | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.455 | |
| 1qxl | FR8 | Adenosine deaminase | 3.5.4.4 | 0.455 | |
| 2etm | 7PY | Focal adhesion kinase 1 | 2.7.10.2 | 0.455 | |
| 2pzp | ACP | Fibroblast growth factor receptor 2 | / | 0.455 | |
| 3fko | FKO | Mitogen-activated protein kinase 14 | / | 0.455 | |
| 4c3f | 7KW | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.455 | |
| 4i3z | ADP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.455 | |
| 4jlc | SU6 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.455 | |
| 4l8u | 9AZ | Serum albumin | / | 0.455 | |
| 4ubs | DIF | Pentalenic acid synthase | 1.14.15.11 | 0.455 | |
| 5hes | 032 | Mitogen-activated protein kinase kinase kinase 20 | 2.7.11.25 | 0.455 | |
| 5itz | LOC | Tubulin beta-2B chain | / | 0.455 | |
| 1s19 | MC9 | Vitamin D3 receptor | / | 0.454 | |
| 2j4z | 626 | Aurora kinase A | 2.7.11.1 | 0.454 | |
| 2osc | MUH | Angiopoietin-1 receptor | 2.7.10.1 | 0.454 | |
| 2y60 | M8F | Isopenicillin N synthase | 1.21.3.1 | 0.454 | |
| 3c0i | 3AM | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.454 | |
| 3e5a | VX6 | Aurora kinase A | 2.7.11.1 | 0.454 | |
| 3fl8 | RAR | Dihydrofolate reductase | / | 0.454 | |
| 3oez | STI | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.454 | |
| 3pjc | PJC | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.454 | |
| 3ttj | JBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.454 | |
| 5k2a | ZMA | Adenosine receptor A2a | / | 0.454 | |
| 1u4d | DBQ | Activated CDC42 kinase 1 | / | 0.453 | |
| 2vbd | V10 | Isopenicillin N synthase | 1.21.3.1 | 0.453 | |
| 3cjg | KIM | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.453 | |
| 3kpk | FAD | Sulfide-quinone reductase | / | 0.453 | |
| 3p6o | ETG | Camphor 5-monooxygenase | 1.14.15.1 | 0.453 | |
| 3tub | FPU | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.453 | |
| 3vry | B43 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.453 | |
| 4fk3 | 325 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.453 | |
| 4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.453 | |
| 4wbo | ANW | Rhodopsin kinase | / | 0.453 | |
| 5iu8 | 6DZ | Adenosine receptor A2a | / | 0.453 | |
| 1gqt | ACP | Ribokinase | / | 0.452 | |
| 1uzw | CDH | Isopenicillin N synthase | 1.21.3.1 | 0.452 | |
| 2jb4 | A14 | Isopenicillin N synthase | 1.21.3.1 | 0.452 | |
| 2p4y | C03 | Peroxisome proliferator-activated receptor gamma | / | 0.452 | |
| 2q61 | SF1 | Peroxisome proliferator-activated receptor gamma | / | 0.452 | |
| 2q70 | DC8 | Estrogen receptor | / | 0.452 | |
| 3eta | 351 | Insulin receptor | 2.7.10.1 | 0.452 | |
| 3kjs | DQ1 | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.452 | |
| 3o56 | ZG1 | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.452 | |
| 3t2y | FAD | Sulfide-quinone reductase | / | 0.452 | |
| 3tqh | NDP | Quinone oxidoreductase | / | 0.452 | |
| 4hw3 | 19G | Induced myeloid leukemia cell differentiation protein Mcl-1 | / | 0.452 | |
| 4oav | ACP | 2-5A-dependent ribonuclease | 3.1.26 | 0.452 | |
| 1cqp | 803 | Integrin alpha-L | / | 0.451 | |
| 1mkd | ZAR | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.451 | |
| 1pjk | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.451 | |
| 1rt4 | UC1 | Gag-Pol polyprotein | 2.7.7.49 | 0.451 | |
| 1uy6 | PU3 | Heat shock protein HSP 90-alpha | / | 0.451 | |
| 2has | C3O | Vitamin D3 receptor | / | 0.451 | |
| 2hog | 710 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.451 | |
| 2po7 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.451 | |
| 2uxo | TAC | HTH-type transcriptional regulator TtgR | / | 0.451 | |
| 2vn0 | TDZ | Cytochrome P450 2C8 | / | 0.451 | |
| 2wot | ZZG | TGF-beta receptor type-1 | 2.7.11.30 | 0.451 | |
| 3clr | FAD | Electron transfer flavoprotein subunit alpha | / | 0.451 | |
| 3cqe | P91 | Wee1-like protein kinase | 2.7.10.2 | 0.451 | |
| 3hll | I45 | Mitogen-activated protein kinase 14 | / | 0.451 | |
| 3r5z | F42 | Uncharacterized protein | / | 0.451 | |
| 4b8m | VX6 | Aurora kinase B-A | 2.7.11.1 | 0.451 | |
| 4elg | 52J | Dihydrofolate reductase | / | 0.451 | |
| 4uyf | 73B | Bromodomain-containing protein 2 | / | 0.451 | |
| 5cvf | ATP | Casein kinase II subunit alpha | 2.7.11.1 | 0.451 | |
| 5uvi | ZMA | Adenosine receptor A2a | / | 0.451 | |
| 1daj | MOT | Dihydrofolate reductase | 1.5.1.3 | 0.450 | |
| 1mc5 | AHE | Alcohol dehydrogenase class-3 | 1.1.1.1 | 0.450 | |
| 2cig | 1DG | Dihydrofolate reductase | 1.5.1.3 | 0.450 | |
| 2wo7 | ASV | Isopenicillin N synthase | 1.21.3.1 | 0.450 | |
| 2z3u | CRR | Cytochrome P450 | / | 0.450 | |
| 3bfa | 9OD | Odorant binding protein ASP1 | / | 0.450 | |
| 3eej | 53R | Uncharacterized protein | / | 0.450 | |
| 3flk | NAI | Tartrate dehydrogenase/decarboxylase | 1.1.1.93 | 0.450 | |
| 3hz1 | 37D | Heat shock protein HSP 90-alpha | / | 0.450 | |
| 4ag8 | AXI | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.450 | |
| 4agc | AXI | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.450 | |
| 4fny | I3K | ALK tyrosine kinase receptor | 2.7.10.1 | 0.450 | |
| 4j6d | TES | Cytochrome P450 monooxygenase | / | 0.450 | |
| 4jq8 | KJ8 | Epidermal growth factor receptor | 2.7.10.1 | 0.450 | |
| 4nmd | FDA | Bifunctional protein PutA | / | 0.450 | |
| 4wkq | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.450 | |
| 5iua | 6DX | Adenosine receptor A2a | / | 0.450 | |
| 1ezf | IN0 | Squalene synthase | 2.5.1.21 | 0.449 | |
| 1kzj | CB3 | Thymidylate synthase | / | 0.449 | |
| 1lri | CLR | Beta-elicitin cryptogein | / | 0.449 | |
| 2hcd | BIV | Vitamin D3 receptor A | / | 0.449 | |
| 3icr | COA | Coenzyme A disulfide reductase | / | 0.449 | |
| 3ics | COA | Coenzyme A disulfide reductase | / | 0.449 | |
| 3p6n | DSO | Camphor 5-monooxygenase | 1.14.15.1 | 0.449 | |
| 3t8x | T8X | T-cell surface glycoprotein CD1b | / | 0.449 | |
| 3vrt | YS2 | Vitamin D3 receptor | / | 0.449 | |
| 3zoi | M2W | Isopenicillin N synthase | 1.21.3.1 | 0.449 | |
| 4cav | MYA | Glycylpeptide N-tetradecanoyltransferase | 2.3.1.97 | 0.449 | |
| 4ddl | 0JQ | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.449 | |
| 4hvh | 19R | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.449 | |
| 4lgg | VGG | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.449 | |
| 4uhr | NGI | Adenosine receptor A2a | / | 0.449 | |
| 1fm7 | DFV | Chalcone--flavonone isomerase 1 | 5.5.1.6 | 0.448 | |
| 1n4h | REA | Nuclear receptor ROR-beta | / | 0.448 | |
| 1sj0 | E4D | Estrogen receptor | / | 0.448 | |
| 2e99 | B08 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.448 | |
| 2fzh | DH1 | Dihydrofolate reductase | 1.5.1.3 | 0.448 | |
| 2ycq | UPX | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.448 | |
| 3ctj | 320 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.448 | |
| 3p6m | DSO | Camphor 5-monooxygenase | 1.14.15.1 | 0.448 | |
| 3sls | 77D | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.448 | |
| 3vrw | YS5 | Vitamin D3 receptor | / | 0.448 | |
| 4alh | A9P | Bromodomain-containing protein 2 | / | 0.448 | |
| 4c7k | NAP | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.448 | |
| 4cjx | 9L9 | C-1-tetrahydrofolate synthase, cytoplasmic, putative | / | 0.448 | |
| 4elb | 34R | Dihydrofolate reductase | / | 0.448 | |
| 4fjz | 4FJ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.448 | |
| 4iw8 | KN3 | Estrogen receptor | / | 0.448 | |
| 3eml | ZMA | Adenosine receptor A2a | / | 0.448 | |
| 1e26 | GPB | Dihydrofolate reductase | 1.5.1.3 | 0.447 | |
| 1fdw | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.447 | |
| 1s6q | TPB | Gag-Pol polyprotein | 2.7.7.49 | 0.447 | |
| 1zg3 | 2HI | Isoflavone 4'-O-methyltransferase | / | 0.447 | |
| 2bfp | H4B | Pteridine reductase 1 | 1.5.1.33 | 0.447 | |
| 2q59 | 240 | Peroxisome proliferator-activated receptor gamma | / | 0.447 | |
| 2ydw | WSH | Bromodomain-containing protein 2 | / | 0.447 | |
| 2zev | B71 | Geranylgeranyl pyrophosphate synthase | / | 0.447 | |
| 3cd2 | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.447 | |
| 3dho | B2M | Streptogramin A acetyltransferase | 2.3.1 | 0.447 | |
| 3kyt | HC2 | Nuclear receptor ROR-gamma | / | 0.447 | |
| 3tda | PN0 | Cytochrome P450 2D6 | / | 0.447 | |
| 4a9m | P9M | Bromodomain-containing protein 2 | / | 0.447 | |
| 4j95 | ACP | Fibroblast growth factor receptor 2 | / | 0.447 | |
| 4ku5 | DCC | 3-oxoacyl-[ACP] synthase III | / | 0.447 | |
| 4xuh | SFI | Peroxisome proliferator-activated receptor gamma | / | 0.447 | |
| 5br4 | NAD | Lactaldehyde reductase | 1.1.1.77 | 0.447 | |
| 1di8 | DTQ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
| 1fml | RTL | Retinol dehydratase | / | 0.446 | |
| 1s1v | TNK | Gag-Pol polyprotein | 2.7.7.49 | 0.446 | |
| 1y57 | MPZ | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.446 | |
| 2dr3 | ADP | UPF0273 protein PH0284 | / | 0.446 | |
| 2e9c | B75 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.446 | |
| 2hw2 | RFP | Rifampin ADP-ribosyl transferase | / | 0.446 | |
| 2ivi | ACW | Isopenicillin N synthase | 1.21.3.1 | 0.446 | |
| 2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.446 | |
| 2y98 | MIV | Mycinamicin IV hydroxylase/epoxidase | / | 0.446 | |
| 3ggf | GVD | Serine/threonine-protein kinase 26 | / | 0.446 | |
| 3qlh | T27 | Gag-Pol polyprotein | 2.7.7.49 | 0.446 | |
| 3uoy | NAP | 2-oxo-Delta(3)-4,5,5-trimethylcyclopentenylacetyl-CoA monooxygenase | 1.14.13.160 | 0.446 | |
| 3uvq | FS8 | Mitogen-activated protein kinase 14 | / | 0.446 | |
| 3vjo | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.446 | |
| 3vt9 | YI4 | Vitamin D3 receptor | / | 0.446 | |
| 3w2o | 03P | Epidermal growth factor receptor | 2.7.10.1 | 0.446 | |
| 4j4v | SVR | Nucleocapsid protein | / | 0.446 | |
| 4jbo | WPH | Aurora kinase A | 2.7.11.1 | 0.446 | |
| 4jvb | 1M0 | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.446 | |
| 4kao | KAO | Focal adhesion kinase 1 | 2.7.10.2 | 0.446 | |
| 4yuq | KS1 | Calmodulin-like domain protein kinase | / | 0.446 | |
| 1nvr | STU | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.445 | |
| 1uy9 | PU6 | Heat shock protein HSP 90-alpha | / | 0.445 | |
| 2bil | BI1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.445 | |
| 2izs | BRQ | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.445 | |
| 2yki | YKI | Heat shock protein HSP 90-alpha | / | 0.445 | |
| 3anl | NDP | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | 1.1.1.267 | 0.445 | |
| 3b2w | 9NH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.445 | |
| 3eel | 53T | Uncharacterized protein | / | 0.445 | |
| 3oib | FDA | Putative acyl-CoA dehydrogenase | / | 0.445 | |
| 3th8 | TH9 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.445 | |
| 3vt5 | YI2 | Vitamin D3 receptor | / | 0.445 | |
| 4aot | GW8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.445 | |
| 4c4h | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.445 | |
| 4c57 | FEF | Cyclin-G-associated kinase | 2.7.11.1 | 0.445 | |
| 4e5y | NDP | GDP-L-fucose synthase | 1.1.1.271 | 0.445 | |
| 4elb | 34S | Dihydrofolate reductase | / | 0.445 | |
| 4fgh | 0U6 | Dihydrofolate reductase | 1.5.1.3 | 0.445 | |
| 4h4o | 506 | Gag-Pol polyprotein | 2.7.7.49 | 0.445 | |
| 4iaq | 2GM | 5-hydroxytryptamine receptor 1B | / | 0.445 | |
| 4ixe | IXE | Dihydrofolate reductase | 1.5.1.3 | 0.445 | |
| 4jx1 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.445 | |
| 4loo | SB4 | Mitogen-activated protein kinase 14 | / | 0.445 | |
| 5aab | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.445 | |
| 1hvy | D16 | Thymidylate synthase | 2.1.1.45 | 0.444 | |
| 1ie4 | T44 | Transthyretin | / | 0.444 | |
| 1kyz | FER | Caffeic acid 3-O-methyltransferase | 2.1.1.68 | 0.444 | |
| 1sqv | UHD | Cytochrome b | / | 0.444 | |
| 2hb7 | O1C | Vitamin D3 receptor | / | 0.444 | |
| 2ycs | NXP | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.444 | |
| 3apf | BMW | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.444 | |
| 3g45 | 988 | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.444 | |
| 3g4g | D71 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.444 | |
| 3gyu | DL7 | Nuclear hormone receptor of the steroid/thyroid hormone receptors superfamily | / | 0.444 | |
| 3hub | 469 | Mitogen-activated protein kinase 14 | / | 0.444 | |
| 3t9i | 3T9 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.444 | |
| 3tvu | B37 | Acetyl-CoA carboxylase | / | 0.444 | |
| 4a33 | MYA | Glycylpeptide N-tetradecanoyltransferase | / | 0.444 | |
| 4bc6 | XZN | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.444 | |
| 4czt | CPS | CBL-interacting serine/threonine-protein kinase 23 | 2.7.11.1 | 0.444 | |
| 4fic | 0UL | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.444 | |
| 4fr4 | STU | Serine/threonine-protein kinase 32A | 2.7.11.1 | 0.444 | |
| 4jqe | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.444 | |
| 4neu | Q1A | Receptor-interacting serine/threonine-protein kinase 1 | 2.7.11.1 | 0.444 | |
| 4qmn | DB8 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.444 | |
| 4tyj | 0LI | Fibroblast growth factor receptor 4 | 2.7.10.1 | 0.444 | |
| 1ad5 | ANP | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.443 | |
| 1m7a | MQU | Dihydrofolate reductase | 1.5.1.3 | 0.443 | |
| 1ppj | SMA | Cytochrome b | / | 0.443 | |
| 2gdo | 12C | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.443 | |
| 2ham | C33 | Vitamin D3 receptor | / | 0.443 | |
| 2pz5 | ACP | Fibroblast growth factor receptor 2 | / | 0.443 | |
| 2wou | ZZF | TGF-beta receptor type-1 | 2.7.11.30 | 0.443 | |
| 3ml8 | ML8 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.443 | |
| 3vqu | O22 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.443 | |
| 3vs0 | VS0 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.443 | |
| 4ead | 0NP | Thymidine phosphorylase | 2.4.2.4 | 0.443 | |
| 4ftt | 6HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.443 | |
| 4g1z | 0VP | Vitamin D3 receptor A | / | 0.443 | |
| 4ge4 | 0KE | Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial | 2.6.1.39 | 0.443 | |
| 4h96 | 14Q | Dihydrofolate reductase | 1.5.1.3 | 0.443 | |
| 4ia7 | BIV | Vitamin D3 receptor A | / | 0.443 | |
| 4qmx | H8H | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.443 | |
| 4rqk | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.443 | |
| 1bvr | THT | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.442 | |
| 1jla | TNK | Gag-Pol polyprotein | 2.7.7.49 | 0.442 | |
| 1k7l | 544 | Peroxisome proliferator-activated receptor alpha | / | 0.442 | |
| 1re9 | DSO | Camphor 5-monooxygenase | 1.14.15.1 | 0.442 | |
| 1s0z | EB1 | Vitamin D3 receptor | / | 0.442 | |
| 1txt | CAA | HMG-CoA synthase | / | 0.442 | |
| 2agv | TG1 | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.442 | |
| 2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.442 | |
| 2chx | 090 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.442 | |
| 2exc | JNK | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.442 | |
| 2wqb | QQ1 | Angiopoietin-1 receptor | 2.7.10.1 | 0.442 | |
| 2ykc | YKC | Heat shock protein HSP 90-alpha | / | 0.442 | |
| 3drc | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.442 | |
| 3eem | 53V | Uncharacterized protein | / | 0.442 | |
| 3lf0 | ATP | Nitrogen regulatory protein P-II | / | 0.442 | |
| 3mnr | SD1 | Heat shock protein HSP 90-alpha | / | 0.442 | |
| 3vt7 | VDX | Vitamin D3 receptor | / | 0.442 | |
| 4fsr | HKC | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
| 4jqh | 1MF | Alr2278 protein | / | 0.442 | |
| 4pkl | 1GH | Uncharacterized protein | / | 0.442 | |
| 4ruo | BIV | Vitamin D3 receptor A | / | 0.442 | |
| 5k2c | ZMA | Adenosine receptor A2a | / | 0.442 | |
| 1dr3 | HBI | Dihydrofolate reductase | 1.5.1.3 | 0.441 | |
| 1fdu | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.441 | |
| 1fp1 | HCC | Isoliquiritigenin 2'-O-methyltransferase | / | 0.441 | |
| 1kyo | SMA | Cytochrome b | / | 0.441 | |
| 1pkf | EPD | Epothilone C/D epoxidase | 1.14 | 0.441 | |
| 1rc1 | KT3 | Trifunctional purine biosynthetic protein adenosine-3 | 2.1.2.2 | 0.441 | |
| 1szm | BI4 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.441 | |
| 1yol | S03 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.441 | |
| 2aib | ERG | Beta-elicitin cinnamomin | / | 0.441 | |
| 2c6h | PXI | Cytochrome P450 monooxygenase PikC | / | 0.441 | |
| 2fm5 | M99 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.441 | |
| 2i9p | NAD | 3-hydroxyisobutyrate dehydrogenase, mitochondrial | 1.1.1.31 | 0.441 | |
| 2jbl | SMA | Reaction center protein L chain | / | 0.441 | |
| 2r0u | M54 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.441 | |
| 2xa4 | AZ5 | Tyrosine-protein kinase JAK2 | / | 0.441 | |
| 3aba | FLI | Cytochrome P450 | / | 0.441 | |
| 3el7 | PD3 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.441 | |
| 3lu8 | IQX | Serum albumin | / | 0.441 | |
| 3mee | T27 | Gag-Pol polyprotein | 2.7.7.49 | 0.441 | |
| 3njo | PYV | Abscisic acid receptor PYR1 | / | 0.441 | |
| 3qaq | QAQ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.441 | |
| 3vt8 | YI3 | Vitamin D3 receptor | / | 0.441 | |
| 3w5e | NVW | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.441 | |
| 3w5p | 4OA | Vitamin D3 receptor | / | 0.441 | |
| 4at3 | LTI | BDNF/NT-3 growth factors receptor | 2.7.10.1 | 0.441 | |
| 4c4f | 7CE | Dual specificity protein kinase TTK | 2.7.12.1 | 0.441 | |
| 4ez8 | DHF | Thymidylate synthase | 2.1.1.45 | 0.441 | |
| 4fgg | 0U5 | Dihydrofolate reductase | 1.5.1.3 | 0.441 | |
| 4fz6 | 0VG | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.441 | |
| 4l42 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.441 | |
| 4n70 | 2HX | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.441 | |
| 4oj4 | DIF | Peroxisome proliferator-activated receptor gamma | / | 0.441 | |
| 1fm9 | 570 | Peroxisome proliferator-activated receptor gamma | / | 0.440 | |
| 1rkh | VD2 | Vitamin D3 receptor | / | 0.440 | |
| 1tl3 | H20 | Gag-Pol polyprotein | 2.7.7.49 | 0.440 | |
| 1uu9 | BI3 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.440 | |
| 1xdd | AAY | Integrin alpha-L | / | 0.440 | |
| 2wtd | ZZK | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.440 | |
| 2ylz | FAD | Phenylacetone monooxygenase | 1.14.13.92 | 0.440 | |
| 2yn8 | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.440 | |
| 2yxu | ATP | Pyridoxal kinase | 2.7.1.35 | 0.440 | |
| 3ar4 | TG1 | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.440 | |
| 3gxo | MQA | Mitomycin biosynthesis 6-O-methyltransferase | / | 0.440 | |
| 3iae | D7K | Benzaldehyde lyase | / | 0.440 | |
| 3mdm | FJZ | Cholesterol 24-hydroxylase | / | 0.440 | |
| 3ol5 | SAW | Camphor 5-monooxygenase | 1.14.15.1 | 0.440 | |
| 3oqu | A8S | Abscisic acid receptor PYL9 | / | 0.440 | |
| 3qlx | QLR | Uncharacterized protein | / | 0.440 | |
| 3s4q | NK0 | Mitogen-activated protein kinase 14 | / | 0.440 | |
| 3sz0 | FAD | Sulfide-quinone reductase | / | 0.440 | |
| 3tkh | 07S | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
| 3w33 | W19 | Epidermal growth factor receptor | 2.7.10.1 | 0.440 | |
| 4a95 | NHW | Glycylpeptide N-tetradecanoyltransferase | / | 0.440 | |
| 4bbx | LKF | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.440 | |
| 4enh | FVX | Cholesterol 24-hydroxylase | / | 0.440 | |
| 4i3w | NAD | Aldehyde dehydrogenase (NAD+) | / | 0.440 | |
| 5cvh | ADP | Casein kinase II subunit alpha | 2.7.11.1 | 0.440 |